ATH 33.3% 0.4¢ alterity therapeutics limited

PBT2 for Middle Ear Infections, page-5

  1. 501 Posts.
    lightbulb Created with Sketch. 49
    It has been acknowledged that PBT2 breaks down antibiotic resistance in bacteria causing middle ear infections. This discovery is the basis for seeking novel applications -like using pbt2 and arsenal. There could be a plethora of applications for scientists to explore. By the way a prestigious award was granted for the cause. Interesting times for ath and it's shareholders!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.